- Announcement under Regulation 30 (LODR)-Newspaper Publication | Announcement04 Mar,2025, 11:50AM IST
Announcement under Regulation 30 (LODR) - Newspaper Publication
- Notice Of Extra Ordinary General Meeting - Wednesday, March 26, 2025 | Announcement03 Mar,2025, 06:02PM IST
Notice of Extra Ordinary General Meeting - Wednesday, March 26, 2025
- Announcement Under Regulation 30 (LODR) - MBL Has Been Awarded By Hon''ble Health Minister Of Ethiopia | Announcement27 Feb,2025, 02:04PM IST
MBL has been recognised and awarded as top No 1 suplier among 160 suplliers worldwide to EPSS for supply of high quality affordable and reliable medicine to reach communities across Ethiopia.
- Announcement under Regulation 30 (LODR)-Issue of Securities | Announcement26 Feb,2025, 04:19PM IST
Announcement under Regulation 30 (LODR)- Issue of Securities
- Announcement Under Regulation 30 Of (LODR)- Clarification On Price Movement | Announcement25 Feb,2025, 04:19PM IST
Clarification on Price Movement
- Clarification sought from Medicamen Biotech Ltd | Announcement24 Feb,2025, 04:51PM IST
The Exchange has sought clarification from Medicamen Biotech Ltd on February 24, 2025 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.
The reply is awaited.
- Board Meeting Intimation for Issunce Of One Or More Instruments Including Equity Shares/Convertible Securities Either By Way Of Preferential Issue/ Right Issue/QIP Or Any Other Mode. | Announcement21 Feb,2025, 04:18PM IST
MEDICAMEN BIOTECH LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/02/2025 ,inter alia, to consider and approve We wish to inform you that a meeting of the Board of Directors is scheduled to be held on Wednesday, February 26, 2025 inter alia, to consider and approve a proposal for raising of funds by way of issuance of one or more instruments including equity shares/convertible securities either by way of Preferential Issue/Right Issue/QIP or any other mode.
- Announcement Under Regulation 30 (LODR)- Updates (Manufacturing And Supply Agreement) | Announcement19 Feb,2025, 05:07PM IST
Announcement under Regulation 30 (LODR)- Updates (Manufacturing and Suppy Agreement)
- Announcement under Regulation 30 (LODR)-Newspaper Publication | Announcement13 Feb,2025, 12:34PM IST
Announcement under Regulation 30 (LODR) - Newspaper Publication
- Announcement under Regulation 30 (LODR)-Change in Management | Announcement11 Feb,2025, 05:37PM IST
Appointment of Mr. Chandan Kumar as Chief Financial Officer and Key Managerial Personnel of the Company w.e.f February 11, 2025
- Financial Results For The Quarter Ended On 31.12.2024 | Announcement11 Feb,2025, 03:53PM IST
Financial Results for the quarter ended on 31.12.2024.
- Integrated Filing (Financial) | Announcement11 Feb,2025, 03:49PM IST
Outcome of Board meeting held on 11.02.2025
- Board Meeting Intimation for Consideration And Approval Of The Standalone And Consolidated Unaudited Financial Results Of The Company For The Quarter Ended On December 31, 2024 | Announcement04 Feb,2025, 05:22PM IST
MEDICAMEN BIOTECH LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2025 ,inter alia, to consider and approve the standalone and consolidated unaudited financial results of the company for the quarter ended on Decmeber 31, 2024.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | Announcement22 Jan,2025, 03:07PM IST
Certificate under Regulation 75 (5) of SEBI (DP) Regulations, 2018
- Intimation Regarding Change Of Name Of Registrar And Share Transfer Agent (RTA) Of The Company | Announcement04 Jan,2025, 12:07PM IST
Intimation regarding change of name of Registrar and Share Transfer Agent (RTA) of the Company
- Closure of Trading Window | Announcement31 Dec,2024, 02:30PM IST
Intimation of Clsoure of Trading Window for the Quarter ending on December 31, 2024
- Clarification On Price Movement | Announcement06 Dec,2024, 05:18PM IST
Clarification on Price Movement
- Clarification sought from Medicamen Biotech Ltd | Announcement06 Dec,2024, 05:03PM IST
The Exchange has sought clarification from Medicamen Biotech Ltd on December 6, 2024 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.
The reply is awaited.
- Announcement under Regulation 30 (LODR)-Newspaper Publication | Announcement06 Dec,2024, 04:03PM IST
Newspaper Advertisement - IEPF
- Announcement under Regulation 30 (LODR)-Newspaper Publication | Announcement15 Nov,2024, 01:59PM IST
Newspaper Publication - Board Meeting 14-11-2024
- Investor Presentation - Q2- 2024 | Announcement14 Nov,2024, 04:49PM IST
Investor Presentation - Q2- 2024
- Outcome Of The Board Meeting Held On 14-11.2024 | Announcement14 Nov,2024, 04:43PM IST
Outcome of the Board Meeting held on 14-11-2024
- Board Meeting Intimation for Considering Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended On September 30,2024 | Announcement07 Nov,2024, 03:12PM IST
MEDICAMEN BIOTECH LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 ,inter alia, to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended on September 30, 2024.
- US FDA Approved The Sterile Injectable Oncology Formulation Facility At Haridwar And Establishment Inspection Report (EIR) Released | Announcement25 Oct,2024, 12:44PM IST
We wish to inform you that the Company has received US FDA approval for the sterile injectable Oncology Formulation facility at Haridwar.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | Announcement09 Oct,2024, 02:32PM IST
Compliance Certificate as per Reg 74(5) of DP Regulations for the quarter ended on 30.09.2024
- Closure of Trading Window | Announcement04 Oct,2024, 12:35PM IST
intimation for closure of Trading Window
- Shareholder Meeting / Postal Ballot-Outcome of AGM | Announcement26 Sep,2024, 06:48PM IST
We hereby submit the summary of the proceedings of the 31st Annual General Meeting of the Company held on Thursday, September 26, 2024 through Video Conferencing / Other Audio Visual means which commenced at 12.00 PM (IST) and concluded at 01.00 PM (IST).
- Announcement under Regulation 30 (LODR)-Trading Plan under SEBI (PIT) Regulations, 2015 | Announcement18 Sep,2024, 02:44PM IST
Intimation as per Regulation 7(3) of PIT Regulations.
- EU GMP Certification Received For BHIWADI Formulation Facility Of Medicamen Biotech Limited. | Announcement11 Sep,2024, 04:43PM IST
EU GMP certification received for Bhiwadi Formulation facility
- Announcement under Regulation 30 (LODR)-Newspaper Publication | Announcement03 Sep,2024, 02:17PM IST
Newspaper Advertisement for the 31st Annual General Meting of the Company
- Corporate Action- Book Closure Intimation | Announcement02 Sep,2024, 10:50AM IST
Book Closure Intimation
- Reg. 34 (1) Annual Report. | Announcement02 Sep,2024, 10:47AM IST
Annual Report for the Financial Year 2023-24
- 31St Annual General Meeting | Announcement02 Sep,2024, 10:43AM IST
This is to inform you that the 31st AGM of the Company will be held on 26.09.2024 through VC/ OAVM
- Announcement under Regulation 30 (LODR)-Newspaper Publication | Announcement14 Aug,2024, 12:14PM IST
Newspaper Publication for the Quarterly Results ended on 30.06.2024 publish at Financial Express and Jansatta
- Business Responsibility and Sustainability Reporting (BRSR) | Announcement13 Aug,2024, 03:23PM IST
Business Responsibility and Sustainability Report for the Financial Year 2023-24
- Board Meeting Outcome for Outcome Of Board Meeting | Announcement13 Aug,2024, 03:21PM IST
In terms of Regulation 33 read with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2024, were approved by the Board of Directors of the Company at its meeting held today at 2:00 P.M. and concluded at 03:00 P.M
- Financial Results For The Quarter Ended On 30.06.2024 | Announcement13 Aug,2024, 03:18PM IST
Financial Results for the quarter ended on 30.06.2024
- Board Meeting Intimation for The Approval Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended On June 30, 2024 And For Approval Of Draft Financial Results For The FY 2023-24 | Announcement07 Aug,2024, 04:00PM IST
MEDICAMEN BIOTECH LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 ,inter alia, to consider and approve Un-audited Financial Results (Standalone & Consolidated) for the quarter ended on June 30, 2024 and for draft Annual Report for the FY 2023-24
- Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) | Announcement25 Jul,2024, 04:47PM IST
Intimation of Resignation of CFO
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | Announcement11 Jul,2024, 11:07AM IST
Certificate under Regulation 74(5) of DP Regulations for the quarter ended on 30.06.2024